Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
04/2005
04/28/2005WO2005037994A2 Transgenic rodents selectively expressing human b1 bradykinin receptor protein
04/28/2005WO2005037991A2 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis
04/28/2005WO2005037990A2 Use of parp inhibitors for prevention and treatment of diabetic and insulin resistance complications
04/28/2005WO2005037988A2 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid
04/28/2005WO2005037987A2 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof
04/28/2005WO2005019431A3 Selective inhibition of toll-like receptor-2
04/28/2005WO2005010165A3 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
04/28/2005WO2005010160A3 Liquid crystals with reduced toxicity and applications thereof
04/28/2005WO2005010155A3 Methods of decoupling reaction scale and protein synthesis yield in batch mode
04/28/2005WO2005007811A3 Injection of bone marrow-derived cells and medium for angiogenesis
04/28/2005WO2005003292A3 Composition and method for self-assembly and mineralization of peptide amphiphiles
04/28/2005WO2005001062A3 Modified vectors for organelle transfection
04/28/2005WO2005001023A3 Method and carrier complexes for delivering molecules to cells
04/28/2005WO2004104167A3 A δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
04/28/2005WO2004099379A3 Use of jag2 expression in diagnosis of plasma cell disorders
04/28/2005WO2004048548A3 Methods for identifying risk of breast cancer and treatments thereof
04/28/2005WO2004048524A3 Modulation of stat2 expression
04/28/2005WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
04/28/2005US20050091238 Performing sequence analysis as a relational join
04/28/2005US20050090646 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors
04/28/2005US20050089991 Apparatus for receiving and aligning a multiple electrode pair array and a multiple treatment cell for use in electroporation
04/28/2005US20050089972 Production of porphyrins
04/28/2005US20050089908 An optimized variant of cyan fluorescent protein (oCFP) containing an amino acid other than tyrosine at position 145.
04/28/2005US20050089902 Methods and compositions for siRNA expression
04/28/2005US20050089492 Compositions containing at least one oil structured with at least one silicone-polyamide polymer, and at least one gelling agent and methods of using the same
04/28/2005CA2548551A1 Shc proteins as therapeutic targets in proliferative diseases
04/28/2005CA2542618A1 Chimeric metabotropic glutamate receptors and uses thereof
04/28/2005CA2542443A1 Methods and compositions related to a matrix chip
04/28/2005CA2542281A1 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof
04/28/2005CA2541166A1 Site-specific incorporation of redox active amino acids into proteins
04/28/2005CA2540210A1 Transgenic rodents selectively expressing human b1 bradykinin receptor protein
04/28/2005CA2512431A1 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis
04/27/2005EP1526174A2 Compositions comprising viruses and methods for concentrating virus preparations
04/27/2005EP1526173A2 Compositions comprising viruses and methods for concentrating virus preparations
04/27/2005EP1525466A2 Transgenic mammals expressing polyglutamine
04/27/2005EP1525465A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
04/27/2005CN1198936C Alzheimer's disease secretase
04/26/2005CA2253871C Ret ligand (retl) for stimulating neural and renal growth
04/21/2005WO2005035731A2 Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists
04/21/2005WO2005035730A2 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain
04/21/2005WO2005035729A2 A genetic screen in drosophila for metastatic behavior
04/21/2005WO2005035728A2 Cell culture methods and devices utilizing gas permeable materials
04/21/2005WO2005035727A2 Polymer derivatives
04/21/2005WO2005035724A2 Cancer-linked genes as targets for chemotherapy
04/21/2005WO2005035723A2 Tyrosinase mutant and methods of use thereof
04/21/2005WO2005035722A2 Variant polypeptides containing plekstrin homology domains and uses therefor
04/21/2005WO2005035721A2 Native immunoglobulin binding reagents and methods for making and using same
04/21/2005WO2005035720A2 Methods and use of binding components for improving assay specificity
04/21/2005WO2005035718A2 Biderectional promoters for small rna expression
04/21/2005WO2005035717A2 Process for the synchronization of ovulation for timed breeding without heat detection
04/21/2005WO2005035716A2 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
04/21/2005WO2005035715A2 Flanking dna sequences that control expression in the human genome
04/21/2005WO2005035714A2 Vaccines for cancer, autoimmune disease and infections
04/21/2005WO2005035713A2 Alternatively spliced variants of human cox1
04/21/2005WO2005035712A2 Methods and compositions for infectious cdna of sars coronavirus
04/21/2005WO2005034871A2 Methods for treating diseases and conditions with inverse agonists
04/21/2005WO2005021705A3 Citrus sesquiterpene synthase, methods of production and uses thereof
04/21/2005WO2005017108A3 Soybean selection system based on aec-resistance
04/21/2005WO2005003296A3 Albumin fusion proteins
04/21/2005WO2004113501A3 Methods and compositions relating to lipid accumulation
04/21/2005WO2004108902A3 Biocompatible fluorescent silicon nanoparticles
04/21/2005WO2004108888A3 Micropositioning cells for tissue engineering
04/21/2005WO2004101769A3 Proteins, sensors, and methods of characterizing analytes using the same
04/21/2005WO2004099373A3 Biocompatible resists
04/21/2005WO2004096987A3 A forward mutation assay based on 5-fluorouracil resistance
04/21/2005WO2004094608A3 Human procolipase like nucleic acids and polypeptides and their methods of use threof
04/21/2005WO2004090112B1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
04/21/2005WO2004090110A3 Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
04/21/2005WO2004087883A3 lovE VARIANT REGULATOR MOLECULES
04/21/2005WO2004083388A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
04/21/2005WO2004078918A3 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides
04/21/2005WO2004072256A3 Variants of cytochrome c and methods of diagnostics of thrombocytopenia
04/21/2005WO2004069992A3 Oligomeric compounds for the modulation of ras expression
04/21/2005WO2004020588A3 Transferrin fusion protein libraries
04/21/2005WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
04/21/2005US20050086712 Method to produce para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promoter
04/21/2005US20050085619 water-soluble compound that includes a polyether or vinyl ether with at least one terminal azide moiety; for linkage of water soluble polymers to a therapeutic agent
04/21/2005US20050084914 Assays with primary cells
04/21/2005US20050084878 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
04/21/2005US20050084495 Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
04/21/2005CA2544733A1 Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists
04/21/2005CA2544611A1 Method of treating airway diseases with beta-adrenergic inverse agonists
04/21/2005CA2542116A1 Cell culture methods and devices utilizing gas permeable materials
04/21/2005CA2541833A1 Tyrosinase mutant and methods of use thereof
04/21/2005CA2540838A1 Process for the synchronization of ovulation for timed breeding without heat detection
04/21/2005CA2540165A1 Native immunoglobulin binding reagents and methods for making and using same
04/21/2005CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
04/20/2005CN1197975C Method for determining polynucleotide sequence variations
04/20/2005CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination
04/14/2005WO2005033294A2 Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage
04/14/2005WO2005033293A2 Hypoxia - responsive human cngh-0002 genes and polypeptides
04/14/2005WO2005033292A2 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof
04/14/2005WO2005033291A2 Hormone response element binding transregulators
04/14/2005WO2005033290A2 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders
04/14/2005WO2005033289A2 Transfection reagents
04/14/2005WO2005033288A2 Hedgehog pathway antagonists
04/14/2005WO2005033287A2 Methods for identifying a biosynthetic pathway gene product
04/14/2005WO2005033286A2 Compositions and methods for synthesizing, purifying and detecting biomolecules
04/14/2005WO2005033285A2 GENE MODULATION BY RB2/p130 EXPRESSION
04/14/2005WO2005033284A2 Compositions and methods for gene expression
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 100